J2182 HCPCS code: Injection, mepolizumab, 1 mg
J2182 is the HCPCS Level II code for injection, mepolizumab, 1 mg. In 2024 Medicare paid an average of $23.42 per service for J2182 across 4,987,291 services. Its Medicare coverage code is C (Carrier judgment): Coverage is decided by the Medicare contractor (MAC) case by case. The NCCI unit limit is 300 per day on outpatient hospital claims. Medicare volume rose 22% from 2022 to 2024 (4,085,969 to 4,987,291 services). In 2024, about 3,014 clinicians billed Medicare for J2182 for 5,165 beneficiaries; Florida, Texas, California accounted for 32% of services.
Code details
| Field | Value |
|---|---|
| Section | J codes — Drugs administered other than oral method |
| Coverage code | C — Carrier judgment |
| Pricing indicator | 51 — Drug or biological (priced per ASP/average sales price rules) |
| BETOS category | O1E — Other drugs |
| Added | 2017-01-01 |
| Last action effective | 2017-01-01 |
Who bills J2182 (2024)
| Measure | Value |
|---|---|
| Clinicians billing (by place of service) | 3,014 |
| Medicare beneficiaries | 5,165 |
| States with claims | 45 |
| Share of services in top 3 states (Florida, Texas, California) | 32% |
Counts only. Supplier and clinician names, contact lists and state-by-state detail are in Caduvo.
Medicare utilization for J2182, 2022–2024
| Year | Services | Beneficiaries | Avg. allowed | Avg. paid |
|---|---|---|---|---|
| 2022 | 4,085,969 | 4,736 | $28.34 | $22.55 |
| 2023 | 4,650,986 | 5,147 | $28.79 | $22.88 |
| 2024 | 4,987,291 | 5,165 | $29.47 | $23.42 |
States with the most J2182 services (2024)
| State | Services | Avg. paid |
|---|---|---|
| Florida | 726,235 | $23.72 |
| Texas | 464,803 | $23.55 |
| California | 396,825 | $22.67 |
| Arizona | 227,020 | $23.48 |
| New York | 220,265 | $23.57 |
NCCI unit limits (MUE)
| Claim type | Max units per day | Rationale |
|---|---|---|
| outpatient hospital claims | 300 | Prescribing Information |
| practitioner claims | 300 | Prescribing Information |
What changed for J2182
- 2017-01-01: J2182 added to HCPCS Level II
- Next scheduled CMS quarterly update (HCPCS and DMEPOS fee schedule): 2027-01-01
Frequently asked questions
What is HCPCS code J2182?
J2182 is the HCPCS Level II code for injection, mepolizumab, 1 mg. Short descriptor: "Injection, mepolizumab, 1mg".
How much does Medicare pay for J2182?
In 2024, the average Medicare payment was $23.42 per service (average allowed $29.47).
Does Medicare cover J2182?
Coverage code C — Carrier judgment. Coverage is decided by the Medicare contractor (MAC) case by case.
How many units of J2182 can be billed per day?
300 on outpatient hospital claims; 300 on practitioner claims (NCCI medically unlikely edits).
Related J21 codes
- J2150 — Injection, mannitol, 25% in 50 ml
- J2151 — Injection, mannitol, 250 mg
- J2170 — Injection, mecasermin, 1 mg
- J2175 — Injection, meperidine hydrochloride, per 100 mg
- J2180 — Injection, meperidine and promethazine hcl, up to 50 mg
- J2183 — Injection, meropenem (wg critical care), not therapeutically equivalent to j2185, 100 mg
- J2184 — Injection, meropenem (b. braun), not therapeutically equivalent to j2185, 100 mg
- J2185 — Injection, meropenem, 100 mg
- J2186 — Injection, meropenem and vaborbactam, 10mg/10mg (20mg)
Building a device that would bill under a code like this? Caduvo matches a device description to HCPCS/CPT codes, Medicare coverage and payment, and the FDA pathway in one report.
Next steps
- Run a reimbursement report for a device billed under J2182
- Watch J2182 for fee, coverage and descriptor changes
- Build a full Medicare revenue model for J2182
Compiled by Caduvo from public CMS (Medicare) records, HCPCS release October 2026. Fees are Medicare allowables, not commercial rates. Not reviewed or endorsed by CMS. Not billing or legal advice. Report an error. Data and corrections policy.